Medicines Patent Pool Expands Its Patent Database To Cancer Treatments
Africa 12/12/2017 •

By Catherine Saez

The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications.

MedsPaL now covers 6,800 national patent applications in more than 110 countries for more than 70 priority treatments, according to a press release. Patent information has been added for seven medications: bendamustine, bevacizumab, dasatinib, imatinib, nilotinib, rituximab and trastuzumab, “as a first step in incorporating additional data on patented medicines on the WHO’s EML [Essential Medicines List],” according to the release.

MPP also announced today that it has signed collaborative agreements with additional patent offices, Argentina’s National Institute of Industrial Property (INPI) and Brazil’s National Institute of Industrial Property (INPI) to augment data on MedsPaL

MedsPaL was funded by Unitaid, and funding provided by the Swiss Agency for Development and Cooperation allowed the upgrade of MedsPaL to include other EML treatments, the release said.

“To support the updating of MedsPaL, the MPP has signed collaborative agreements with the European Patent Office (EPO), Argentina’s National Institute of Industrial Property (INPI), Chile’s National Institute of Industrial Property (INAPI), Dominican Republic’s National Office of Industrial Property (ONAPI), Ecuador Industrial Property Institute (IEPI), El Salvador’s National Registry Center (CNR) and South Africa’s Companies and Intellectual Property Commission (CIPC),” the release added.

The MPP made a presentation of MedsPaL at the World Intellectual Property Organization Standing Committee on the Law of Patents this morning.

The Medicines Patent Pool (MPP) has signed collaborative agreements with additional patent offices, Argentina’s National Institute of Industrial Property (INPI) and Brazil’s National Institute of Industrial Property (INPI) to augment data on MedsPaL

Combat the infodemic in health information and support health policy reporting from the global South. Our growing network of journalists in Africa, Asia, Geneva and New York connect the dots between regional realities and the big global debates, with evidence-based, open access news and analysis. To make a personal or organisational contribution click here on PayPal.